These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25864833)

  • 21. Revolution II--you better change your mind instead. By Caveman.
    J Cell Sci; 2011 Sep; 124(Pt 17):2873-5. PubMed ID: 21878494
    [No Abstract]   [Full Text] [Related]  

  • 22. [Side effects of anticancer treatment and the needs for translational research on toxicity: a clinician's perspective].
    Shimizu C
    Nihon Yakurigaku Zasshi; 2015 Aug; 146(2):72-5. PubMed ID: 26256743
    [No Abstract]   [Full Text] [Related]  

  • 23. Translational Research Symposium-collaborative efforts as driving forces of healthcare innovation.
    Coentro JQ; De Pieri A; Gaspar D; Tsiapalis D; Zeugolis DI; Bayon Y
    J Mater Sci Mater Med; 2019 Dec; 30(12):133. PubMed ID: 31792698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report concludes industry-academia partnerships on the wane.
    Shaffer C
    Nat Biotechnol; 2010 Jan; 28(1):7-8. PubMed ID: 20062022
    [No Abstract]   [Full Text] [Related]  

  • 25. University of Rochester expands PhD program to focus on infectious disease research.
    Printz C
    Clin Transl Sci; 2015 Apr; 8(2):86. PubMed ID: 26079016
    [No Abstract]   [Full Text] [Related]  

  • 26. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
    Renger JJ; Kern JT
    J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
    [No Abstract]   [Full Text] [Related]  

  • 27. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Build a medical plants production system by the industry-academia-government collaboration consortium].
    Goto K
    Nihon Yakurigaku Zasshi; 2016; 148(6):315-321. PubMed ID: 27904011
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of academic medicine for innovations in development of drugs and biomedicine technology].
    Manns MP
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1993-4. PubMed ID: 24065403
    [No Abstract]   [Full Text] [Related]  

  • 30. Perestroika in pharma: evolution or revolution in drug development?
    FitzGerald GA
    Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug firm, relenting, allows unflattering study to appear.
    Altman LK
    N Y Times Web; 1997 Apr; ():A1, A16. PubMed ID: 11647207
    [No Abstract]   [Full Text] [Related]  

  • 32. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational psychiatry--light at the end of the tunnel.
    Jones KA; Menniti FS; Sivarao DV
    Ann N Y Acad Sci; 2015 May; 1344():1-11. PubMed ID: 25752480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New NIH center broadens scope of translational research.
    Jenks S
    J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
    [No Abstract]   [Full Text] [Related]  

  • 35. Sisyphus and translational stroke research.
    Lyden P; Lapchak P
    Sci Transl Med; 2012 Oct; 4(156):156ps20. PubMed ID: 23076354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor reports dog industry-academia liaison.
    Ready T
    Nat Med; 2002 Dec; 8(12):1338-9. PubMed ID: 15085880
    [No Abstract]   [Full Text] [Related]  

  • 37. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.
    Kamel N; Compton C; Middelveld R; Higenbottam T; Dahlén SE
    Eur Respir J; 2008 May; 31(5):924-6. PubMed ID: 18448501
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?
    Eichler HG; Kong SX; Grégoire JP
    Eur J Health Econ; 2006 Jun; 7(2):129-35. PubMed ID: 16485122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology--mutual benefits from greater collaboration between academia and the pharmaceutical industry.
    Posner J
    Br J Clin Pharmacol; 1991 Nov; 32(5):531-3. PubMed ID: 1954067
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical drug information profit or knowledge orientated.
    Worthen DB
    Ethics Sci Med; 1976 Dec; 3(4):235-45. PubMed ID: 1031666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.